Anuh Pharma Board Approves Dividend of ₹1.50 Per Share

The Board of Directors of Anuh Pharma Limited approved the audited financial results for the quarter and financial year ended March 31, 2026. They recommended a dividend of ₹1.50 per equity share (30% payout on face value of ₹5 each), subject to shareholder approval. The board also approved the re-appointment of Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal as directors retiring by rotation, and the appointment of Mr. P. N. Rao as General Manager - Quality and M/s. RMJ & Associates LLP as Internal Auditors. Additionally, they approved the re-appointment of Ankit Kishor Chande as Cost Auditor. The 66th Annual General Meeting will be held on August 12, 2026, via video conferencing.